Medical and Recreational
Marijuana Company Kaya Holdings, Inc. (OTCQB:KAYS)
Set to Launch Retail Cannabis Delivery Service and Advances Plans
for Kaya Cares Opioids-Cannabis Exchange Program
Note: Please click here to watch a
video created by Group Nine Media on the Kaya Cares Opiods-Cannabis
Exchange Program. As of Sunday Evening there were already over
5,000 likes
or cut and paste this link:
https://m.facebook.com/story.php?story_fbid=1535010739914719&id=899640933451706
Ft. Lauderdale, FL -- December 11, 2017 -- InvestorsHub NewsWire
-- Kaya Holdings, Inc. (OTCQB:KAYS),
announced today that it has completed the processes necessary to
launch its own home delivery service in Portland and Salem Oregon.
The Company expects to operate 4 cars initially, with additional
cars to be added as demand requires and as the company expands into
other cities in Oregon.
In addition to providing added value and convenience for our
customers, extending visibility and building brand recognition for
the Kaya ShackTM brand, we believe that Home Delivery provides
greater market penetration, by allowing sales throughout the
geographic area that our stores are licensed in. There is no limit
to the number of delivery vehicles that can service an individual
area using just one store as a home base, so in effect we intend to
use this service to construct additional "virtual" Kaya ShacksTM
without the added costs of additional brick and mortar
locations.
"We believe that this delivery service is the next step in the
implementation of our business plan and part of our efforts to
increase sales as we work to lower costs", states Kaya Holdings CEO
Craig Frank. "The delivery service", Frank continues, "will permit
the company to serve all areas of Portland and Salem bringing the
opportunity for all residents over the age of 21 to benefit from
and enjoy our distinctive blend of high-quality cannabis at fair
prices. We look forward to serving our existing customers and the
many new customers we expect to bring into the Kaya Shack
family".
Additionally, KAYS confirmed that it continues to discuss
implementation options with its attorneys for its Kaya Cares
Opioid-Cannabis Exchange Program and expect to be launching the
program in January. "We have spoken with our attorneys and have
worked with them to structure a program that will allow individuals
currently using opioids for pain management to explore the efficacy
of cannabis for their needs at no cost to them," states CEO Frank.
"Our goal is to assist in the reduction of tragic deaths and
destroyed lives that the opioid epidemic has inflicted on opioid
addicts, their families, and all of us", adds Kaya Holdings Senior
Advisor W. David Jones. "We're just trying to do our part".
The Kaya Cares program has received tremendous public support,
which the Company appreciates and hopes continues to drive a
conversation on the use of cannabis as a safe and effective opioid
substitute. An example of the public support received is:
https://m.facebook.com/story.php?story_fbid=1535010739914719&id=899640933451706
Save the Date- KAYS Conference Call December 20, 2017 1:00 PM
EST
KAYS Shareholders and other interested parties are reminded to
sign up for the Kaya Holdings Annual Shareholder Call on Wednesday,
December 20, 2017 at 1:00 P.M. EST. The call is expected to last
between 60-90 minutes. Among the topics to be discussed are Kaya
Shack stores, OLCC licensing update, new brands to be introduced in
2018, an industry overview, and the acquisition of farmland and the
development of Kaya Farms.
About Kaya Holdings, Inc.
(www.kayaholdings.com)
KAYS (OTCQB:KAYS),
through subsidiaries, produces, distributes and sells legal premium
medical and recreational cannabis products, including flower,
concentrates and oils, and cannabis-infused foods.
In 2014, KAYS, became the first publicly traded company to own
and operate a Medical Marijuana Dispensary. KAYS presently operates
three Kaya Shack OLCC licensed marijuana retail stores to service
the legal medical and recreational marijuana market in Oregon, with
store number four currently under construction. Additionally, KAYS
recently acquired a 26 acre parcel which it has targeted for
development of the Kaya Farms Medical and Recreational Marijuana
Grow and Manufacturing Complex.
IMPORTANT DISCLOSURE: KAYS is planning execution of its stated
business objectives in accordance with current understanding of
State and Local Laws and Federal Enforcement Policies and
Priorities as it relates to Marijuana (as outlined in the Justice
Department's Cole Memo dated August 29, 2013), and plan to proceed
cautiously with respect to legal and compliance issues. Potential
investors and shareholders are cautioned that AFAI and MJAI will
obtain advice of counsel prior to actualizing any portion of their
business plan (including but not limited to license applications
for the cultivation, distribution or sale of marijuana products,
engaging in said activities or acquiring existing Cannabis
production/sales operations). Advice of counsel with regard to
specific activities of KAYS and MJAI, Federal, State or Local legal
action or changes in Federal Government Policy and/or State and
Local Laws may adversely affect business operations and shareholder
value.
Forward Looking Statements
This press release includes statements that may constitute
"forward-looking" statements, usually containing the words
"believe," "estimate," "project," "expect" or similar expressions.
These statements are made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. Factors that would cause or
contribute to such differences include, but are not limited to,
acceptance of the Company's current and future products and
services in the marketplace, the ability of the Company to develop
effective new products and receive regulatory approvals of such
products, competitive factors, dependence upon third-party vendors,
and other risks detailed in the Company's periodic report filings
with the Securities and Exchange Commission. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this release.
For more information contact Investor Relations:
954-892-6911.